By use-case framing, the market is classified into weight management and cardiovascular risk anchored indications
She had lost a total of 30 pounds, and her A1C level had improved further to 6.8%
Weight-loss surgery effectively reduces weight and complications in patients with severe obesity
Systematic review of 26 RCTs
Potential cost: $500-900/month Potential savings: $200-400/month How it works: Enter your medication and zip code, compare prices at different pharmacies, show the coupon at checkout
In patients with HFpEF and obesity, both semaglutide (STEP-HFpEF) and tirzepatide (SUMMIT) significantly reduced cardiovascular death and worsening heart failure events, with concomitant improvements in quality of life and functional capacity [3,47]